How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Venous Thromboembolism - Cancer Related

ACCRU-SC-1601, A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six months of Anticoagulation Therapy

  • Women or Men ages 18 or older, with cancer and greater than 6 months but less than one year of anticoagulant therapy

Select Clinical Trial

Venous Thromboembolism - Cancer Related

Clara McLean House
Make a Donation
News & Events